Article Details

Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic ...

Retrieved on: 2024-04-06 17:22:59

Tags for this article:

Click the tags to see associated articles and topics

Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic .... View article details on hiswai:

Excerpt

... Data from the EMERGENT Program Evaluating KarXT ... analysis included 718 patients who received at least one dose of KarXT, with 134 patients having ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up